1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is 7,51€ (+22.936,81%). The median is 7,51€ (+22.936,81%).
| Buy |
2 |
| Hold |
3 |
| Sell |
0 |
News Go to news feed
Vicarious Surgical cuts 2025 cash-burn forecast to $45 million
Vicarious Surgical has lowered its 2025 cash-burn forecast from $50 million to about $45 million, citing disciplined cost management and operational realignment. The company plans to issue a cash-burn forecast for 2026 before year-end. Board committees were restructured; Q3 figures showed significantly reduced operating expenses and a smaller net loss, while the stock is trading near its 52-week low. » More on de.investing.com
Financials
| (EUR) | Mar 2026 | |
|---|---|---|
| Revenue | 0.00 | - |
| Gross profit | −158.09k | - |
| Net profit | −6.33m | 55,50% |
| EBITDA | −6.17m | 55,55% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 211.33k€ |
Number of shares | 6.48m |
52-week high/low | 6,63€ - 0,0258€ |
| Dividends | No |
Beta | 1,92 |
P/E ratio | −0,01 |
PEG ratio | 0,00 |
P/B ratio | 0,07 |
P/S ratio | 0,00 |
Company profile
| Name | Vicarious Surgical |
| CEO | Stephen From |
| Headquarters | Waltham,
ma USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Technology |
| Employees | 48 |
Discover assets
Shareholders of Vicarious Surgical also invest in the following assets
